Dr. Devanshi Mehta, M.D
Pulmonology (Pulmonary Disease Physician)
- Medicare participating
At a glance
- Years since graduation
- 14
- In the NPI registry since
- 2015
- Medicare patients seen, 2024
- 97
Licensed in Texas since 2023, according to the Texas Medical Board. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. What an NPI is
Education and training
- 2015Registered with an NPI (national billing number; not a license date)
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Pulmonary Disease Physician primary
TX license U7013 (first issued 2023; active) -
Internal Medicine Physician
TX license U7013 (first issued 2023; active)
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Christus Mother Frances Hospital Tyler, TX
- Ut Health East Texas Tyler Regional Hospital Tyler, TX
- Ut Health East Texas Athens Hospital Athens, TX
- University of Texas Health Science Center at Tyler Tyler, TX
- Ut Health East Texas Henderson Hospital Henderson, TX
Medical groups
- University of Texas Health Science Center at Tyler-Facilty-Physician (122 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 97
- Services billed
- 139
- Patients’ average age
- 73
| Service | Times | Patients |
|---|---|---|
| Critical care, first 30-74 minutes | 83 | 73 |
| Insertion of non-tunneled central venous tube for infusion (5 years or older) | 16 | 15 |
| Established patient office or other outpatient visit, 20-29 minutes | 14 | 14 |
| Emergent insertion of breathing tube into windpipe using an endoscope | 13 | 12 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Payments from drug and device companies
In 2025, 13 companies reported 48 payments worth $824 in total to this clinician.
| GlaxoSmithKline, LLC. | $225 |
|---|---|
| Insmed, Inc. | $217 |
| Genzyme Corporation | $84.18 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $58.92 |
| Merck Sharp & Dohme LLC | $48.04 |
| AstraZeneca Pharmaceuticals LP | $35.95 |
| Paratek Pharmaceuticals, Inc. | $34.61 |
| Electromed, Inc. | $29.58 |
| Food and Beverage | $824 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.